Madeline E. Byrd

• Representing Lek Pharmaceuticals d.d. and Sandoz Inc. in a patent infringement action relating to the drug ibrutinib (Imbruvica®). Pharmacyclics LLC, et al. v. Zydus Worldwide DMCC, et al., No. 1:18-cv-00275 (D. Del.).
• Represented Hubei Grand Life Science and Technology Co. Ltd. in an IPR proceeding which resulted in all challenged claims being found unpatentable. Hubei Grand Life Science and Technology Co. Ltd. v. Vitaworks IP LLC, IPR No. 2018-01766.

Maddy Byrd is an associate with Alston & Bird’s Intellectual Property Litigation Group. Maddy received her J.D., magna cum laude, from New York University School of Law. During law school, she was the senior articles editor for the NYU Journal of Intellectual Property & Entertainment Law. She received her B.A. in chemistry, magna cum laude, from Pepperdine University.

Bar Admissions

• New York
• U.S. Patent and Trademark Office

Education

• New York University (J.D., 2019)
• Pepperdine University (B.A., 2016)